NewAmsterdam Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAMS and other ETFs, options, and stocks.About NAMS
NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol.
CEOMichael H. Davidson
CEOMichael H. Davidson
Employees68
Employees68
HeadquartersNaarden, Noord-Holland
HeadquartersNaarden, Noord-Holland
Founded2022
Founded2022
Employees68
Employees68
NAMS Key Statistics
Market cap2.01B
Market cap2.01B
Price-Earnings ratio-9.73
Price-Earnings ratio-9.73
Dividend yield—
Dividend yield—
Average volume617.24K
Average volume617.24K
High today$18.48
High today$18.48
Low today$17.50
Low today$17.50
Open price$18.03
Open price$18.03
Volume69.91K
Volume69.91K
52 Week high$27.29
52 Week high$27.29
52 Week low$14.06
52 Week low$14.06
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own NAMS. This list is generated using Robinhood data, and it’s not a recommendation.